Undervalued, High Growth Solar Company Set to Soar

Currently on a $25M revenue run-rate, Solar Integrated Roofing Corp. (OTC - SIRC) may offer the greatest upside of any company in the solar space. The stock trades at a big discount to its peers, and although it trades above its 50 and 200 DMAs, this underfollowed player hasn't yet enjoyed the big moves of its peers.

Read more...
 
Great Q, New LOIs: IQST Grossly Undervalued

With its core business ahead of forecasts and business development accelerating its initiatives, we affirm our target price and project a marked share volume increase in IQST as well.

Read more...
 
Undervalued Pain Management Innovator Set for Exponential Gains

Electromedical Technologies, Inc. (OTCQB – EMED) is an FDA-cleared bioelectronics provider poised to introduce a new product that could drive exponential sales and serve as an alternative to opioids.

Read more...
 
Greatest Upside, Limited Downside

Telecom services provider iQSTEL, Inc. (OTC - IQST) is evolving, adding new markets and offerings which are driving growth beyond $40M in sales mark in 2020, and should take the valuation to new heights, even at a discount to its peer group.

Read more...
 
Raising Price Target on Findit

We are raising our price target on Findit, Inc. (OTC - FDIT) by 20% due to stronger than expected traction with customers and what we believe will be a steady stream of new members/clients, including Goldman Small Cap Research.

Read more...
 
PetVivo: Innovation and Leverage Could Result in Huge New Market Opportunity

PetVivo Holdings, Inc. (OTC - PETV) has nearly doubled since our Sector Spotlight in June. It now appears that innovation and IP leverage could bring a new huge market opportunity to the company.

Read more...
 
Oranco Trending in the Right Direction

Oranco, Inc. (OTC - ORNC) appear to be trending in the right direction as we await updated financial results.

Read more...
 
The Next Great Social Media Co

Findit appears to have designed a better mousetrap for SMBs and individuals, improving outcomes and business conversions compared to typical methods and offerings.

Read more...
 
New Price Target for PAOG

On the heels of updated reporting and strong technicals, we are introducing a new 12 month price target for PAO Group (OTC - PAOG - NR) that is nearly 5x its current stock price.

Read more...
 
Under the Radar CBD Pharma Player Could Offer Major Upside

Following the close of strategic acquisitions, emerging CBD Pharma company PAO Group, Inc. (OTC - PAOG - NR) is a company to watch closely as it could enjoy a major rise in value as it completes key milestones.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 45